2022 NHMRC Synergy Grant - new funding to create new drugs to fight emerging viruses and antibiotic-resistant superbugs

2022 NHMRC Synergy Grant - new funding to create new drugs to fight emerging viruses and antibiotic-resistant superbugs

22 Oct 21 schroder.admin Funding 0 Comments

2022 NHMRC Synergy Grant

"Mining the host-pathogen interface to deliver a drug pipeline for treating intractable and emerging infections"

Emerging viruses and antibiotic-resistant superbugs are the most important challenge to human health in the 21st century. New viruses such as SARS-CoV2 and Zika, as well as antibiotic resistant superbugs, emerge regularly and rapidly, urgently requiring new therapies.

Kate is leading the multidisciplinary Synergy team, including Prof Mark von Itzstein (Griffith Uni), Dr Lara Herrero (Griffith Uni), Prof Mark Walker (UQ) and Emer Prof Maree Smith (UQ). This team has demonstrated success in drug development and will work together to create new drugs to avert the imminent global health disaster posed by emerging viruses and superbugs.

Brava to all!

Posted by schroder.admin

ABOUT Inflammasome Lab

Inflammasome Lab is a group of researchers led by Prof Kate Schroder at the Institute for Molecular Bioscience, The University of Queensland.
We seek to unravel the secrets of inflammasomes – protein complexes at the heart of inflammation and disease – to allow for new therapies to fight human diseases.